RNAConnect

RNAConnect specializes in providing advanced reverse transcriptase solutions, particularly through its UltraMarathonRT (uMRT) product. The company operates in the biotechnology sector, focusing on enhancing RNA sequencing accuracy and efficiency. Its primary clients include researchers and organizations involved in gene expression, regulation research, cell gene therapy, and diagnostics for oncology, rare diseases, and infectious diseases. RNAConnect's business model revolves around selling its proprietary uMRT kits, which offer high fidelity and ultra-processive cDNA synthesis. The uMRT product is designed to outperform conventional reverse transcriptases by offering unique intrinsic helicase activity and optimal performance at ambient temperatures, preserving RNA integrity. This positions RNAConnect as a key player in accelerating discovery and innovation across the research to clinic continuum. Keywords: reverse transcriptase, RNA sequencing, gene therapy, diagnostics, oncology, rare diseases, infectious diseases, cDNA synthesis, biotechnology, research.